Reaction Details Report a problem with these data
Target
Vasopressin V2 receptor
Ligand
BDBM50077139
Substrate
n/a
Meas. Tech.
ChEMBL_1474010 (CHEMBL3419770)
Kd
>1000±n/a nM
Citation
 Karpenko, IA; Margathe, JF; Rodriguez, T; Pflimlin, E; Dupuis, E; Hibert, M; Durroux, T; Bonnet, D Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay. J Med Chem 58:2547-52 (2015) [PubMed]  Article 
Target
Name:
Vasopressin V2 receptor
Synonyms:
ADHR | AVPR V2 | AVPR2 | Antidiuretic hormone receptor | DIR | DIR3 | Renal-type arginine vasopressin receptor | V2R | V2R_HUMAN | VASOPRESSIN V2 | Vasopressin V2 receptor | Vasopressin receptor
Type:
Receptor
Mol. Mass.:
40295.28
Organism:
Homo sapiens (Human)
Description:
P30518
Residue:
371
Sequence:
MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS
  
Inhibitor
Name:
BDBM50077139
Synonyms:
CHEMBL3416752
Type:
Small organic molecule
Emp. Form.:
C63H72ClF4N7O19
Mol. Mass.:
1342.728
SMILES:
[O-]C(=O)C(F)(F)F.COc1ccc(c[nH+]1)-n1c(COCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCNC(=O)c2ccc(c(c2)C(O)=O)-c2c3ccc(O)cc3oc3cc(=O)ccc23)nnc1N1CC(C1)Oc1ccc(F)cc1Cl |(9.24,30.38,;9.24,29.14,;8.17,28.53,;10.57,28.37,;11.64,28.99,;11.64,27.76,;10.57,27.14,;-30.83,47.13,;-29.98,46.24,;-28.48,46.61,;-27.42,45.5,;-25.92,45.86,;-25.5,47.34,;-26.56,48.45,;-28.05,48.09,;-24.03,47.82,;-22.79,46.94,;-22.78,45.4,;-21.45,44.63,;-21.44,43.09,;-20.11,42.32,;-20.1,40.78,;-18.77,40.02,;-18.76,38.48,;-17.43,37.71,;-17.42,36.17,;-16.09,35.4,;-16.08,33.86,;-14.75,33.09,;-14.74,31.55,;-13.41,30.78,;-13.4,29.24,;-12.06,28.48,;-12.06,26.93,;-10.72,26.17,;-10.72,24.63,;-9.38,23.86,;-9.38,22.32,;-8.04,21.55,;-8.04,20.01,;-6.7,19.24,;-6.7,17.7,;-5.36,16.93,;-5.36,15.39,;-6.42,14.77,;-4.02,14.63,;-4.02,13.09,;-2.68,12.32,;-2.68,10.78,;-1.34,10.01,;-1.34,8.47,;-0,7.7,;1.06,8.32,;0,6.16,;-1.33,5.39,;-1.33,3.85,;0,3.08,;1.34,3.85,;1.34,5.39,;2.67,3.09,;2.68,2.06,;3.74,3.7,;,1.54,;-1.33,.77,;-2.67,1.54,;-4,.77,;-4,-.77,;-5.07,-1.39,;-2.67,-1.54,;-1.33,-.77,;,-1.54,;1.31,-.77,;2.67,-1.54,;4,-.77,;5.07,-1.39,;4,.77,;2.67,1.54,;1.31,.77,;-21.54,47.83,;-22.02,49.29,;-23.56,49.29,;-24.47,50.53,;-25.93,50.85,;-25.57,52.35,;-24.07,51.98,;-26.36,53.66,;-25.62,55.01,;-24.08,55.04,;-23.33,56.39,;-24.13,57.71,;-23.54,58.79,;-25.67,57.68,;-26.41,56.33,;-27.65,56.31,)|
Structure:
Search PDB for entries with ligand similarity: